Elevated plasma cholesteryl ester transfer in NIDDM: Relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein

Atherosclerosis

Volumn 140, Issue 1, 1998, Pages 71-79

  Riemens, Stephen ^a   Van Tol, Arie ^b   Sluiter, Wim ^a   Dullaart, Robin ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Cholesterol esterification; Cholesteryl ester transfer; Cholesteryl ester transfer protein; Hepatic lipase; High density lipoproteins; Lecithin:cholesterol acyl transferase; Lipoprotein lipase; Non insulin dependent diabetes mellitus; Phospholipid transfer protein

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID TRANSFER PROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL ESTERIFICATION; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY RISK; ENZYME ACTIVITY; HUMAN; LIPOPROTEIN METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHOSPHOLIPID METABOLISM; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL;

ADULT; AGED; APOLIPOPROTEINS B; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; GLYCOPROTEINS; HUMANS; LIPOPROTEIN LIPASE; LIVER; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PHOSPHOLIPID TRANSFER PROTEINS;

EID: 0032171437     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00111-7     Document Type: Article

References (62)

1. Taskinen M.R. Hyperlipidaemia in diabetes. Baillières Clin Endocrinol Metab. 4:1990;743-775.
2. Bierman E.L. Atherogenesis in diabetes. Arterioscler Thromb. 12:1992;647-656.
3. Lehto S., Rönnemaa T., Haffner S.M., Pyörälä K., Kallio V., Laakso M. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-age patients with NIDDM. Diabetes. 46:1997;1354-1359.
4. Fielding C.J., Fielding P.E. Molecular physiology of reverse cholesterol transport. J Lipid Res. 36:1995;211-228.
5. Bruce C., Tall A.R. Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis. Curr Opin Lipidol. 6:1995;306-311.
6. Barter P.J., Rye K.A. Molecular mechanisms of reverse cholesterol transport. Curr Opin Lipidol. 7:1996;82-87.
7. Eisenberg S. High density lipoprotein metabolism. J Lipid Res. 25:1984;1017-1058.
8. Dullaart R.P.F., Groener J.E.M., Erkelens D.W. Cholesteryl ester transfer between lipoproteins. Diabetes Nutr Metab. 14:1991;329-343.
9. Tall A.R. Plasma cholesteryl ester transfer protein. J Lipid Res. 34:1993;1255-1274.
10. Tu A.Y., Nishida H.I., Nishida T. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem. 268:1993;23098-23105.
11. Tollefson J.H., Ravnik S., Albers J.J. Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J Lipid Res. 29:1988;1593-1602.
12. Jauhiainen M., Metso J., Pahlman R., Blomqvist S., van Tol A., Ehnholm C. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem. 268:1993;4032-4036.
13. 1-HDL. Biochim Biophys Acta. 1301:1996;255-262.
14. Lusa S., Jauhiainen M., Metso J., Somerharju P., Ehnholm C. The mechanism of plasma lipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. Biochem J. 313:1996;275-282.
15. Hennessy L.K., Kunitake S.T., Kane J.P. Apolipoprotein A-I-containing lipoproteins, with or without apolipoprotein A-II, as progenitors of pre-β high-density lipoprotein particles. Biochemistry. 32:1993;5759-5765.
16. Jansen H., van Tol H., Hulsmann W.C. On the metabolic function of heparin-releasable liver lipase. Biochem Biophys Res Commun. 92:1980;53-59.
17. Fielding C.J., Reaven G.M., Fielding P.E. Human non-insulin-dependent diabetes: identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein E. Proc Natl Acad Sci USA. 79:1982;6365-6369.
18. Fielding C.J., Reaven G.M., Liu G., Fielding P.E. Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer. Proc Natl Acad Sci USA. 81:1984;2512-2516.
19. Bagdade J.D., Lane J.T., Subbaiah P.V., Otto M.E., Ritter M.C. Accelerated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus. Atherosclerosis. 104:1993;69-77.
20. Sutherland W.H., Walker R.J., Lewis-Barned N.J., Pratt H., Tillman H.C. Plasma cholesteryl ester transfer in patients with non-insulin dependent diabetes mellitus. Clin Chim Acta. 231:1994;29-38.
21. Elchebly M., Porokhov B., Pulcini T., Berthezène F., Ponsin G. Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus (NIDDM). Atherosclerosis. 123:1996;93-101.
22. Bhatnagar D., Durrington P.N., Kumar S., Mackness M.I., Boulton A.J.M. Plasma lipoprotein composition and cholesteryl ester transfer from high density lipoproteins to very low density and low density lipoproteins in patients with non-insulin-dependent diabetes mellitus. Diabetic Med. 13:1996;139-144.
23. Bagdade J.D., Kelley D.E., Henry R.R., Eckel R.H., Ritter M.C. Effects of multiple daily insulin injections and intraperitoneal insulin therapy on cholesteryl ester transfer and lipoprotein lipase activities in NIDDM. Diabetes. 46:1997;414-420.
24. Lottenberg S.A., Lottenberg A.M.P., Nunes V.S., McPherson R., Quintao E.C.R. Plasma cholesteryl ester transfer protein concentration, high-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins in the fasting state and after a test meal are similar in Type II diabetics and normal controls. Atherosclerosis. 127:1996;81-90.
25. Ahnadi C.E., Masmoudi T., Berthezène F., Ponsin G. Decreased ability of high density lipoproteins to transfer cholesterol esters in non-insulin-dependent diabetes mellitus. Eur J Clin Invest. 23:1993;459-465.
26. Kahri J., Syvänne M., Taskinen M.R. Plasma cholesteryl ester transfer protein activity in non-insulin-dependent diabetic patients with and without coronary artery disease. Metabolism. 43:1994;1498-1502.
27. van Tol A. CETP-catalysed transfer of cholesterylesters from HDL to apo B-containing lipoproteins in plasma from diabetic patients (letter). Eur J Clin Invest. 23:1993;856.
28. Dullaart R.P.F., Sluiter W.J., Dikkeschei L.D., Hoogenberg K., van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest. 24:1994;188-194.
29. Dullaart R.P.F., Hoogenberg K., Dikkeschei B.D., van Tol A. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioscler Thromb. 14:1994;1581-1585.
30. van Tol A., Ligtenberg J.J.M., Riemens S.C., van Haeften T.W., Reitsma W.D., Dullaart R.P.F. Lowering of plasma phospholipid transfer protein activity by acute hyperglycaemia-induced hyperinsulinaemia in healthy men. Scan J Clin Lab Invest. 57:1997;147-158.
31. National Diabetes Data Group Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 28:1979;1039-1057.
32. 2 cholesterol level in older adults. New Engl J Med. 322:1990;229-234.
33. Demacker P.N., Hijmans A.G., Vos-Janssen H.E., van't Laar A., Jansen A.P. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein. Clin Chem. 26:1980;1775-1779.
34. Hindriks F.R., Wolthers B.G., Groen A. The determination of total cholesterol in serum by gas-liquid chromatography compared with two other methods. Clin Chim Acta. 74:1977;207-215.
35. Channon K.M., Clegg R.J., Bhatnagar D., Ishola M., Arrol S., Durrington P.N. Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transfer. Atherosclerosis. 80:1990;217-226.
36. Glomset J.A., Wright J.L. Some properties of a cholesterol esterifying enzyme in human plasma. Biochim Biophys Acta. 89:1964;266-267.
37. Groener J.E.M., Pelton R.W., Kostner G.M. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem. 32:1986;283-286.
38. Hannuksela M., Marcel Y.L., Kesäniemi Y.A., Savolainen M.J. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res. 33:1992;737-744.
39. Floren C.H., Chen C.H., Franzen J., Albers J.J. Lecithin: cholesterol acyltransferase in liver disease. Scand J Clin Lab Invest. 47:1987;613-617.
40. Speijer H., Groener J.E.M., van Ramshorst E., van Tol A. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis. 90:1991;159-168.
41. Jansen H., Hop W., van Tol A., Bruschke A.V.G., Birkenhager J.C. Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease. Atherosclerosis. 107:1994;45-54.
42. Mann C.J., Yen F.T., Grant A.M., Bihain B.E. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest. 88:1991;2059-2066.
43. Eisenberg S. Preferential enrichment of large-sized very low density lipoprotein with transferred cholesteryl esters. J Lipid Res. 26:1985;487-494.
44. Lagrost L., Florentin E., Guyard-Dangremont V., Athias A., Gandjini H., Lallemant C., Gambert P. Evidence for non-esterified fatty acids as modulators of neutral lipid transfers in normolipidemic human plasma. Arterioscler Thromb Vasc Biol. 15:1995;1388-1396.
45. Passarelli M., Catanozi S., Nakandakare E.R., Rocha J.C., Morton R.E., Shimabukuro A.F.M., Quintao E.C.R. Plasma lipoproteins from patients with poorly controlled diabetes mellitus and in vitro glycation of lipoproteins enhance the transfer rate of cholesteryl ester from HDL to apo B-containing lipoproteins. Diabetologia. 40:1997;1085-1093.
46. Dullaart R.P.F., Groener J.E., Dikkeschei B.D., Erkelens D.W., Doorenbos H. Increased cholesterylester transfer activity in complicated type 1 insulin-dependent diabetes mellitus: its relationship with serum lipids. Diabetologia. 32:1989;14-19.
47. Elchebly M., Pulcini T., Porokhov B., Berthezène F., Ponsin G. Multiple abnormalities in the transfer of phospholipids from VLDL and LDL to HDL in non-insulin-dependent diabetes. Eur J Clin Invest. 26:1996;216-223.
48. Syvänne M., Castro G., Dengremont C., Geitere De C., Jauhiainen M., Ehnholm C., Michelagnoli S., Franceschini G., Kahri J., Taskinen M.R. Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer assay. Atherosclerosis. 127:1996;245-253.
49. Schernthaner G., Kostner G.M., Dieplinger H., Prager R., Mühlhauser I. Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin:cholesterol acyltransferase activity in diabetes mellitus. Atherosclerosis. 49:1983;277-293.
50. Durlach V., Attia N., Zahouani A., Leutenegger M., Girard-Globa A. Postprandial cholesteryl ester transfer and high density lipoprotein composition in normotriglyceridemic non-insulin-dependent diabetic patients. Atherosclerosis. 120:1996;155-165.
51. Murakami T., Michelagnoli S., Longhi R., Gianfranceschi G., Pazzucconi F., Calabresi L., Sirtori C.R., Franceschini G. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol. 15:1995;1819-1828.
52. Clay M.A., Newnham H.H., Forte T.M., Barter P.J. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo AI from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta. 1124:1992;52-58.
53. Jiang X., Francone O.L., Bruce C., Milne R., Mar J., Walsh A., Breslow J.L., Tall A.R. Increased preβ-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J Clin Invest. 96:1996;2373-2380.
54. Albers J.J., Tu A.Y., Paigen B., Chen H., Cheung M.C., Marcovina S.M. Transgenic mice expressing human phospholipid transfer protein have increased HDL/non-HDL cholesterol ratio. Int J Clin Lab Res. 26:1996;262-267.
55. Ishida B.Y., Frolich J., Fielding C.J. Pre-beta-migrating high density lipoprotein: quantitation in normal and hyperlipidemic plasma by solid phase radioimmunoassay following electrophoretic transfer. J Lipid Res. 28:1987;778-786.
56. Syvänne M., Ahola M., Lahdenperä S., Kahri J., Kuusi T., Virtanen K.S., Taskinen M.R. High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J Lipid Res. 36:1995;573-582.
57. Frénais R., Ouguerram K., Maugeais C., Mahot P., Maugère P., Krempf M., Magot T. High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study. Diabetologia. 40:1997;578-583.
58. Tall A.R., Granot E., Brocia R., Tabas I., Hesler C., Williams K., Denko M. Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein. J Clin Invest. 79:1987;1217-1225.
59. Marotti K.R., Castle C.K., Boyle T.P., Lin A.H., Murray R.W., Melchior G.W. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature. 364:1993;73-75.
60. Inazu A., Brown M.L., Hesler C.B., Agellon L.B., Koizumi J., Takata K., Maruhama Y., Mabuchi H., Tall A.R. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. New Engl J Med. 323:1990;1234-1238.
61. Hayek T., Masucci-Magoulas L., Jiang X., Walsh A., Rubin E., Breslow J.L., Tall A.R. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest. 96:1995;2071-2074.
62. Zhong S., Sharp D.S., Grove J.S., Bruce C., Yano K., Curb J.D., Tall A.R. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest. 97:1996;2917-2923.